©The Author(s) 2025.
World J Gastroenterol. Oct 21, 2025; 31(39): 111261
Published online Oct 21, 2025. doi: 10.3748/wjg.v31.i39.111261
Published online Oct 21, 2025. doi: 10.3748/wjg.v31.i39.111261
Figure 2 Distribution of multidrug-resistant organism species in colonization and infection episodes among intensive care unit admi ssions.
Stacked bar shows the proportions of bacterial species in colonization’s episodes (left) and infection episodes (right). MDRO: Multidrug-resistant organism; E. coli: Escherichia coli; ESBL: Extended-spectrum beta-lactamase; OXA-48: Oxacillinase-48; K. pneumoniae: Klebsiella pneumoniae; KPC: Klebsiella pneumoniae carbapenemase; MDR: Multidrug-resistant; VRE: Vancomycin-resistant Enterococcus spp.; MRSA: Methicillin-resistant Staphylococcus aureus.
- Citation: Kosuta I, Babel J, Domislovic V, Susak F, Peretin L, Varda Brkic D, Marekovic I, Radonic R, Mrzljak A. Clinical impact of multidrug-resistant organisms in liver cirrhosis: A retrospective cohort study in the intensive care setting. World J Gastroenterol 2025; 31(39): 111261
- URL: https://www.wjgnet.com/1007-9327/full/v31/i39/111261.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i39.111261